Biopsy criteria for determining appropriateness for active surveillance in the modern era

Urology

Volumn 83, Issue 4, 2014, Pages 869-874

  Kryvenko, Oleksandr N ^a   Carter, H Ballentine ^b   Trock, Bruce J ^b   Epstein, Jonathan I ^a,b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; AGED; ALGORITHM; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CAUCASIAN; COHORT ANALYSIS; EPSTEIN CRITERIA; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTION; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RACE DIFFERENCE; TUMOR BIOPSY; VALIDATION STUDY;

ADULT; AFRICAN AMERICANS; AGED; ALGORITHMS; BIOPSY; COHORT STUDIES; EARLY DETECTION OF CANCER; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 84897132627     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2013.12.054     Document Type: Article

References (29)

1. J.I. Epstein, P.C. Walsh, and M. Carmichael et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer JAMA 271 1994 368 374
2. J.J. Tosoian, E. JohnBull, and B.J. Trock et al. Pathological outcomes in men with low risk and very low risk prostate cancer: implications on the practice of active surveillance J Urol 190 2013 1218 1222
3. J.J. Tosoian, B.J. Trock, and P. Landis et al. Active surveillance program for prostate cancer: an update of the Johns Hopkins experience J Clin Oncol 29 2011 2185 2190
4. J.I. Epstein, W.C. Allsbrook Jr., and M.B. Amin et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Am J Surg Pathol 29 2005 1228 1242
5. S. Karram, B.J. Trock, and G.J. Netto et al. Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings Am J Surg Pathol 35 2011 1351 1355
6. S.A. Brassell, T.C. Kao, and L. Sun et al. Prostate-specific antigen versus prostate-specific antigen density as predictor of tumor volume, margin status, pathologic stage, and biochemical recurrence of prostate cancer Urology 66 2005 1229 1233
7. A.M. Wise, T.A. Stamey, and J.E. McNeal et al. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens Urology 60 2002 264 269
8. T.O. Al-Hussain, and J.I. Epstein Initial high-grade prostatic intraepithelial neoplasia with carcinoma on subsequent prostate needle biopsy: findings at radical prostatectomy Am J Surg Pathol 35 2011 1165 1167
9. T. Wolters, M.J. Roobol, and P.J. van Leeuwen et al. A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial J Urol 185 2011 121 125
10. P.C. Albertsen, J.A. Hanley, and G.H. Barrows et al. Prostate cancer and the Will Rogers phenomenon J Natl Cancer Inst 97 2005 1248 1253
11. H.M. Ross, O.N. Kryvenko, and J.E. Cowan et al. Do adenocarcinomas of the prostate with Gleason score (GS)
12. H.B. Carter, A.W. Partin, and P.C. Walsh et al. Gleason score 6 adenocarcinoma: should it be labeled as cancer? J Clin Oncol 30 2012 4294 4296
13. H.B. Carter, J. Sauvageot, and P.C. Walsh et al. Prospective evaluation of men with stage T1C adenocarcinoma of the prostate J Urol 157 1997 2206 2209
14. A.C. Reese, P. Landis, and M. Han et al. Expanded criteria to identify men eligible for active surveillance of low risk prostate cancer at Johns Hopkins: a preliminary analysis J Urol 190 2013 2033 2038
15. C.D. Yeom, S.H. Lee, and K.K. Park et al. Are clinically insignificant prostate cancers really insignificant among Korean men? Yonsei Med J 53 2012 358 362
16. Y. Komai, N. Numao, and S. Yoshida et al. High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy J Urol 190 2013 867 873
17. N. Numao, S. Kawakami, and M. Sakura et al. Characteristics and clinical significance of prostate cancers missed by initial transrectal 12-core biopsy BJU Int 109 2012 665 671
18. S.R. Bott, M.P. Young, and M.J. Kellett et al. Anterior prostate cancer: is it more difficult to diagnose? BJU Int 89 2002 886 889
19. T.M. Koppie, F.J. Bianco Jr., and K. Kuroiwa et al. The clinical features of anterior prostate cancers BJU Int 98 2006 1167 1171
20. K.T. Mai, M. Moazin, and C. Morash et al. Transitional zone and anterior peripheral zone of the prostate. A correlation of small-volume cancer in the biopsy cores and high PSA with positive anterior margins in radical prostatectomy specimens Urol Int 66 2001 191 196
21. S. Kawakami, K. Kihara, and Y. Fujii et al. Transrectal ultrasound-guided transperineal 14-core systematic biopsy detects apico-anterior cancer foci of T1c prostate cancer Int J Urol 11 2004 613 618
22. N. Arumainayagam, H.U. Ahmed, and C.M. Moore et al. Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard Radiology 268 2013 761 769
23. H. Takeshita, N. Numao, and T. Kijima et al. Diagnostic performance of initial transperineal 14-core prostate biopsy to detect significant cancer Int Urol Nephrol 45 2013 645 652
24. J. Philip, S. Dutta Roy, and J. Scally et al. Importance of TURP in diagnosing prostate cancer in men with multiple negative biopsies Prostate 64 2005 200 202
25. N.B. Delongchamps, M. Rouanne, and T. Flam et al. Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging BJU Int 107 2011 1411 1418
26. R.F. Sanchez-Ortiz, P. Troncoso, and R.J. Babaian et al. African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men Cancer 107 2006 75 82
27. M.R. Abern, M.R. Bassett, and M. Tsivian et al. Race is associated with discontinuation of active surveillance of low-risk prostate cancer: results from the Duke Prostate Center Prostate Cancer Prostatic Dis 16 2013 85 90
28. V. Iremashvili, M.S. Soloway, and D.L. Rosenberg et al. Clinical and demographic characteristics associated with prostate cancer progression in patients on active surveillance J Urol 187 2012 1594 1599
29. M. Tsivian, L.L. Banez, and C.J. Keto et al. African-American men with low-grade prostate cancer have higher tumor burdens: results from the Duke Prostate Center Prostate Cancer Prostatic Dis 16 2013 91 94